Journal
EXPERIMENTAL PHYSIOLOGY
Volume 108, Issue 5, Pages 740-751Publisher
WILEY
DOI: 10.1113/EP090172
Keywords
CAFs; ezrin; gastric cancer; PDPN; tumourigenesis
Categories
Ask authors/readers for more resources
The role and biological mechanism of PDPN in the progression of gastric cancer were revealed in this study. PDPN acted as a promoter in the progression of gastric cancer through the activation of Ezrin expression and CAFs, providing a new route for gene-targeted therapy. These findings have important implications for the treatment of gastric cancer.
New FindingsWhat is the central question of this study?To reveal the role and biological mechanism of PDPN in the progression of gastric cancer.What is the main finding and its importance?This study focused on a prognostic predictor, PDPN, which acted as a promoter in the progression of gastric cancer through the activation of Ezrin expression and CAFs. This finding may expand a new route for the gene-targeted therapy in gastric cancer. Gastric cancer (GC) is a frequent malignant disease and the main cause of cancer-related death in the world. Podoplanin (PDPN) has been proved to be involved in the progression of various cancers. However, the role and biological mechanism of PDPN in GC are still vague. In our study, we detected the expression of PDPN in GC tissues and cell lines using RT-qPCR, western blot and datasets. The overall survival of GC patients was analysed with a Kaplan-Meier plot. The effects of PDPN overexpression and silencing on GC cell progression were assessed by Cell Counting Kit-8, flow cytometry and a wound healing assay. Besides, the modulation of PDPN on ezrin activation was investigated. We further explored the role of PDPN in the crosstalk between GC cells and cancer associated fibroblasts (CAFs). Results showed that PDPN was upregulated in GC tissues and cell lines. High expression of PDPN was correlated with poor prognosis of GC patients. PDPN positively regulated the viability, migration and invasion, but inhibited apoptosis, of GC cells by mediating the activation of ezrin. Meanwhile, the change in PDPN in GC cells activated CAFs and promoted the production of cytokines secreted by CAFs, which induced the progression of GC cells. These findings may provide a novel target for GC therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available